Men Who Ejaculate Less Than Four Times Monthly May Face Higher Prostate Cancer Risk – Doctor
Medical expert cites long-term Harvard research linking ejaculation frequency to prostate health
By Online Editor
A Nigerian medical expert, Dr. Rasheed Abassi, has said that men who ejaculate fewer than four times a month may face a 33 percent higher risk of developing prostate cancer, citing findings from a long-term Harvard University study.
Speaking during an interview on The Morayo Show, Dr. Abassi explained that the research, which followed thousands of men over several years, found a connection between low ejaculation frequency and an increased likelihood of prostate cancer. According to him, men who ejaculated more frequently appeared to have a lower risk of the disease.
The physician attributed the finding to what he described as the “stagnation theory,” suggesting that regular ejaculation may help clear potentially harmful substances from the prostate, reducing prolonged exposure to compounds that could contribute to cancer development. He noted, however, that prostate cancer is influenced by multiple factors, including age, family history, genetics, diet and lifestyle.
While discussing the research, Dr. Abassi referenced a Harvard study that has been widely cited in medical literature. The study found that men reporting 21 or more ejaculations per month had a lower risk of being diagnosed with prostate cancer compared with those who ejaculated less frequently. Researchers stressed that the findings show an association rather than definitive proof that ejaculation alone prevents prostate cancer.
Medical experts also advise that men should not rely solely on ejaculation frequency as a preventive strategy. Maintaining a healthy lifestyle, avoiding smoking, eating a balanced diet, exercising regularly and attending routine medical screenings—especially for men over 50 or those with a family history of prostate cancer—remain important steps in reducing overall risk.
Prostate cancer is one of the most common cancers affecting men worldwide. In many cases, the disease develops slowly and may not produce symptoms in its early stages, making regular medical check-ups and early detection essential for successful treatment.
